Numerous Journals Featuring CytexOrtho Technology
News
Venture Connect 2024
CytexOrtho was thrilled to participate in this year's Venture Connect! The event offers a platform to 'gain visibility and potential financial backing while championing the great innovation emerging from this region.' Organized by CED and now in its 40th year, Venture...
MedTech Innovator Road Show Event
MedTech Innovator's mission "is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system," and CytexOrtho was excited to have been selected to participate! CytexOrtho was selected as one of the approximately...
DeviceTalks Weekly Podcast: Our chat with AAOS pitch winner CytexOrtho
From devicetalks.com: "In this episode of the DeviceTalks Weekly Podcast, Co-hosts Tom Salemi and Chris Newmarker interview Brad Estes, CEO of CytexOrtho, the winner of a pitch contest staged by AAOS. The company is developing implants that could serve as an...
2024 OrthoPitch Winner!
We’re super proud of our CEO, Brad Estes, Ph.D., as he impressed the audience and judges alike to lead CytexOrtho to victory at the first inaugural AAOS OrthoPitch competition! Our sincere thanks to MCRA and American Academy of Orthopaedic Surgeons (AAOS) for giving...
AAOS OrthoPitch 2024
CytexOrtho is excited to be selected as a finalist at the inaugural OrthoPitch contest next week at AAOS! CytexOrtho’s CEO, Dr. Brad Estes, will be battling it out with three other startups for the prizes and bragging rights at a brand-new technology competition for...
Newsletter – January 2024
The January 2024 issue of the CytexOrtho newsletter covers our 2023 accomplishments, including receiving Breakthrough Device Designation from the FDA, and highlights what is on the horizon in 2024: the plan for hosting our first clinical trial and the launch of our...
Newsletter – June 2023
The June issue of the CytexOrtho newsletter covers our successful crowdfunding raise, our progress toward clinical trials, and our talk on capitol hill! If you would like to receive a copy of our future newsletters, be sure to sign up for our mailing lists via the...
CytexOrtho on Capital Hill
On May 11th, 2023 Dr Brad Estes, CytexOrtho Co-founder and CEO, traveled to Washington D.C. to sit on a panel about the state of osteoarthritis (OA) in the United States, and the need for additional funding to move scientific advances combating OA to the clinic. The...
Breakthrough Device Designation from the FDA
We are thrilled to announce that we just received a Breakthrough Device Designation from the United States Food and Drug Administration (FDA) for our novel hip cartilage repair technology. The intent of the Breakthrough Devices Program1 is to help patients have...
October Newsletter
The October issue of the CytexOrtho newsletter covers our progression toward clinical trials, discussions with the FDA, and our new CRP award from NIH! If you would like to receive a copy of our future newsletters, be sure to sign up for our mailing lists via the...